# Bisphosphonates for the Treatment of Seropositive Musculoskeletal Complaints

> **NCT04115397** · PHASE4 · UNKNOWN · sponsor: **Karolinska Institutet** · enrollment: 80 (estimated)

## Conditions studied

- Seropositive Muskuloskeletal Complaints

## Interventions

- **DRUG:** Zoledronic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04115397
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115397, "Bisphosphonates for the Treatment of Seropositive Musculoskeletal Complaints". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04115397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*